OPLAH

5-oxoprolinase, ATP-hydrolysing, the group of MicroRNA protein coding host genes

Basic information

Region (hg38): 8:144051266-144063965

Links

ENSG00000178814NCBI:26873OMIM:614243HGNC:8149Uniprot:O14841AlphaFoldGenCCjaxSfariGnomADPubmedClinVar

Phenotypes

GenCC

Source: genCC

  • 5-oxoprolinase deficiency (Strong), mode of inheritance: AR
  • 5-oxoprolinase deficiency (Supportive), mode of inheritance: AR

Clinical Genomic Database

Source: CGD

ConditionInheritanceIntervention CategoriesIntervention/Rationale Manifestation CategoriesReferences
5-oxoprolinase deficiencyARGeneralGenetic knowledge may be beneficial related to issues such as selection of optimal supportive care, informed medical decision-making, prognostic considerations, and avoidance of unnecessary testingBiochemical; Gastrointestinal; Renal6113726; 6790862; 8127060; 21651516
Transient neonatal hypoglycemia has been reported

ClinVar

This is a list of variants' phenotypes submitted to ClinVar and linked to the OPLAH gene.

  • 5-Oxoprolinase deficiency (12 variants)
  • not provided (1 variants)

Variants pathogenicity by type

Statistics on ClinVar variants can assist in determining whether a specific variant type in the OPLAH gene is commonly pathogenic or not.

In the table, we include only reliable ClinVar variants with their consequences to MANE Select, Mane Plus Clinical transcripts, or transcripts with TSL equals 1. Click the count to view the source variants.

Warning: slight differences between displayed counts and the number of variants in ClinVar may occur, primarily due to (1) the application of a different transcript and/or consequence by our variant effect predictor or (2) differences in clinical significance: we classify Benign/Likely benign variants as Likely benign and Pathogenic/Likely pathogenic variants as Likely pathogenic.

Variant type Pathogenic Likely pathogenic VUS Likely benign Benign Sum
synonymous
7
clinvar
72
clinvar
17
clinvar
96
missense
1
clinvar
185
clinvar
23
clinvar
14
clinvar
223
nonsense
6
clinvar
4
clinvar
10
start loss
0
frameshift
6
clinvar
1
clinvar
7
inframe indel
0
splice donor/acceptor (+/-2bp)
1
clinvar
3
clinvar
4
splice region
5
13
2
20
non coding
7
clinvar
31
clinvar
7
clinvar
45
Total 13 9 199 126 38

Highest pathogenic variant AF is 0.0000591

Variants in OPLAH

This is a list of pathogenic ClinVar variants found in the OPLAH region.

You can filter this list by clicking the number of variants in the Variants pathogenicity by type table.

Position Type Phenotype Significance ClinVar
8-144051332-G-T Likely benign (Dec 01, 2022)2658964
8-144051350-A-G 5-Oxoprolinase deficiency Likely benign (Aug 09, 2022)1134698
8-144051362-G-A 5-Oxoprolinase deficiency Likely benign (Jan 22, 2024)3016028
8-144051370-G-A 5-Oxoprolinase deficiency Uncertain significance (Nov 22, 2022)2130705
8-144051371-C-T 5-Oxoprolinase deficiency Likely benign (Feb 03, 2023)2894841
8-144051372-T-A 5-Oxoprolinase deficiency Benign/Likely benign (Sep 30, 2023)1169835
8-144051373-C-T 5-Oxoprolinase deficiency Likely benign (Dec 12, 2023)1130802
8-144051385-G-A 5-Oxoprolinase deficiency Likely benign (Feb 02, 2023)788262
8-144051397-G-GCGACACCGGCGGTGGGGCGGGGT OPLAH-related disorder Likely pathogenic (Sep 27, 2024)3355213
8-144051406-G-A not specified Uncertain significance (Jan 05, 2022)2389856
8-144051440-A-G 5-Oxoprolinase deficiency Likely benign (Aug 09, 2022)1573775
8-144051448-C-G 5-Oxoprolinase deficiency Uncertain significance (Mar 27, 2022)1908069
8-144051480-C-G Likely benign (Sep 01, 2023)2658965
8-144051482-CG-C 5-Oxoprolinase deficiency Benign (Dec 29, 2023)2072722
8-144051482-C-CG 5-Oxoprolinase deficiency Benign (Jan 29, 2024)1599755
8-144051484-G-C 5-Oxoprolinase deficiency Uncertain significance (Jun 15, 2022)2155576
8-144051485-G-A 5-Oxoprolinase deficiency Likely benign (Jun 05, 2022)1552957
8-144051487-G-T 5-Oxoprolinase deficiency Likely benign (Nov 29, 2022)2890686
8-144051488-G-C 5-Oxoprolinase deficiency Benign/Likely benign (Jan 17, 2024)1551741
8-144051489-GGGC-G 5-Oxoprolinase deficiency Likely benign (Dec 30, 2023)1661448
8-144051490-GGC-G 5-Oxoprolinase deficiency Likely benign (Jan 25, 2024)1594896
8-144051491-GC-G 5-Oxoprolinase deficiency Benign (Jan 25, 2024)1169394
8-144051492-C-G 5-Oxoprolinase deficiency Benign (Jan 31, 2024)1600681
8-144051721-G-A 5-Oxoprolinase deficiency Benign/Likely benign (Jul 30, 2021)714648
8-144051732-G-A 5-Oxoprolinase deficiency Likely benign (Sep 21, 2022)2059388

GnomAD

Source: gnomAD

GeneTypeBio TypeTranscript Coding Exons Length
OPLAHprotein_codingprotein_codingENST00000426825 2712569
pLI Probability
LOF Intolerant
pRec Probability
LOF Recessive
Individuals with
no LOFs
Individuals with
Homozygous LOFs
Individuals with
Heterozygous LOFs
Defined p
6.97e-170.93519252105234341245200.607
Z-Score Observed Expected Observed/Expected Mutation Rate Total Possible in Transcript
Missense0.2658168380.9740.00005708098
Missense in Polyphen328369.130.888573532
Synonymous-0.02423683671.000.00002602807
Loss of Function2.333452.20.6520.00000272559

LoF frequencies by population

EthnicitySum of pLOFs p
African & African-American2.001.49
Ashkenazi Jewish1.000.686
East Asian1.000.695
Finnish1.000.305
European (Non-Finnish)1.000.602
Middle Eastern1.000.695
South Asian1.000.789
Other1.000.649

dbNSFP

Source: dbNSFP

Function
FUNCTION: Catalyzes the cleavage of 5-oxo-L-proline to form L- glutamate coupled to the hydrolysis of ATP to ADP and inorganic phosphate.;
Disease
DISEASE: 5-oxoprolinase deficiency (OPLAHD) [MIM:260005]: A disorder characterized by calcium oxalate/carbonate urolithiasis, and excessive urinary 5-oxo-L-proline. Affected individuals have recurrent episodes of vomiting, diarrhea, and abdominal pain. {ECO:0000269|PubMed:21651516}. Note=The disease is caused by mutations affecting the gene represented in this entry.;
Pathway
Glutathione metabolism - Homo sapiens (human);Gamma-glutamyl-transpeptidase deficiency;5-oxoprolinase deficiency;Gamma-Glutamyltransferase Deficiency;Glutathione Metabolism;Glutathione Synthetase Deficiency;5-Oxoprolinuria;Glutathione metabolism;Glutathione conjugation;Phase II - Conjugation of compounds;Biological oxidations;Metabolism;γ-glutamyl cycle;Glutathione synthesis and recycling (Consensus)

Recessive Scores

pRec
0.186

Haploinsufficiency Scores

pHI
0.118
hipred
N
hipred_score
0.315
ghis

Gene Damage Prediction

AllRecessiveDominant
MendelianMediumMediumMedium
Primary ImmunodeficiencyMediumMediumMedium
CancerMediumMediumMedium

Mouse Genome Informatics

Gene name
Oplah
Phenotype
behavior/neurological phenotype (the observable actions or reactions of mammalian organisms that are manifested through development and lifespan); hematopoietic system phenotype; cardiovascular system phenotype (the observable morphological and physiological characteristics of the mammalian heart, blood vessels, or circulatory system that are manifested through development and lifespan); limbs/digits/tail phenotype;

Gene ontology

Biological process
glutathione metabolic process;glutathione biosynthetic process
Cellular component
cytosol
Molecular function
ATP binding;5-oxoprolinase (ATP-hydrolyzing) activity